Overall, PP2A-B56 has been established to function as a tumor suppressor, diminishing the activation of master oncogenic regulators, including extracellular signal-regulated kinases (ERK), protein kinase B (AKT), and p53. The gene discussed is TP53; the disease is neoplasm.